AmpliTech Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 12, 2026, reporting third-quarter and nine-month financial results along with an updated balance sheet showing total assets of $76,132,104.
Vuzix Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 12, 2026, disclosing a nine-month net loss of $23,086,207 and cash holdings that declined to $9,192,134 from $21,150,213 at year-end 2025.
Relmada Therapeutics, Inc. filed a current report on November 12, 2026, announcing preliminary and unaudited financial results for the third fiscal quarter ended September 30, 2026, along with an updated corporate presentation.
Knightscope, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on November 12, 2026, announcing its financial results for the third quarter ended September 30, 2026.
Knightscope, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission, disclosing share counts, going-concern language, and forward-looking risk factors as of November 12, 2026.
Boa Acquisition Corp. II filed a Form 10-Q with the SEC on November 12, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, its first quarter following its Initial Public Offering.
AIRO Group Holdings, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, and trading on NASDAQ:AIRO.
Spartacus Acquisition Corp. II filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026.
BioCardia, Inc. filed its quarterly report on Form 10-Q with the SEC on November 12, 2026, covering the three and nine months ended September 30, 2026, disclosing continued operating losses and a reduced cash position compared to December 31, 2025.
Cyngn Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting financial results for the three and nine months ended that date.